Life Sciences Real Estate Demand Shrinks as R&D Absorbs Funding

Life Sciences Real Estate Demand Shrinks as R&D Absorbs Funding

It’s a time of contraction for the life sciences industry, as executives at major biosciences firms attempt to decipher not only how to create the next big drug, but also where to locate facilities for the next wave of product development.

The industry, made up of drug makers and biological research and development types, takes up a wide array of properties, including research labs, offices, healthcare equipment manufacturing facilities and distribution ce

Register to view the full article

This article is part of our premium content subscription. You need to subscribe to gain access to premium content.

Why Register for NREIonline? It's simple and free, and here is what you get:

• Access to leading real estate industry research.
• Interactive rankings of commercial real estate professionals.
• Submit your own articles, (if approved) which will appear around the site.

Already a member? .

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish